Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study Assessing Two Strategies of First Line: a Strategy With Intraperitoneal Chemotherapy and a Strategy With Total Intravenous Strategy, in Patients With Epithelial Advanced Ovarian Cancer

NCT03025477 is registered in ClinicalTrials.gov with Groupe Hospitalier Diaconesses Croix Saint-Simon as lead sponsor.

NCT NCT03025477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03025477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study Assessing Two Strategies of First Line: a Strategy With Intraperitoneal Chemotherapy and a Strategy With Total Intravenous Strategy, in Patients With Epithelial Advanced Ovarian Cancer
Lead sponsor
Groupe Hospitalier Diaconesses Croix Saint-Simon
Phase
Phase 2
Overall status
Recruiting
Start date
October 31, 2016
Completion date
October 31, 2032
Enrollment
84 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, epithelial